Mario Rivas - Dec 15, 2021 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role: Chief Executive Officer, Director
Signature: /s/ Cameron McAulay, Attorney-in-Fact
Stock symbol: TGAN
Transactions as of: Dec 15, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/17/2021, 03:07 PM
Next filing: Jan 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TGAN	Common Stock	Award	$0	+28K	+26.51%	$0.00	134K	Dec 15, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TGAN	Stock Option (right to buy)	Award	$0	+42K		$0.00	42K	Dec 15, 2021	Common Stock	42K	$7.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a Restricted Stock Unit ("RSU"). One third (1/3) of the RSUs will vest on each of November 15, 2022, November 15, 2023 and November 15, 2024, in each case subject to the Reporting Person's continued status as a Service Provider to the Issuer through each vesting date.
F2	One-third (1/3) of the shares subject to the option will vest on November 15, 2022, and the remaining shares vest in equal monthly installments over the following 24 months, subject to the Reporting Person's continued service as of each such vesting date.